Role of the sub-cellular localization of RasGAP fragment N2 for its ability to sensitize cancer cells to genotoxin-induced apoptosis

Experimental Cell Research

Volumn 315, Issue 12, 2009, Pages 2081-2091

  Annibaldi, Alessandro ^a   Michod, David ^a   Vanetta, Linda ^a   Cruchet, Steeve ^a   Nicod, Pascal ^b   Dubuis, Gilles ^a   Bonvin, Christelle ^a   Widmann, Christian ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Apoptosis; Cancer; Fixation artefact; Genotoxin; Immunocytochemistry; RasGAP; Sensitization; Sub cellular localization

Indexed keywords

CISPLATIN; PROTEIN N2; PROTEIN RASGAP; RAS PROTEIN; RHO FACTOR; TOXIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL FRACTIONATION; CELL ORGANELLE; CELLULAR DISTRIBUTION; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOPLASM; DRUG RESPONSE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 67349144394     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.03.015     Document Type: Article

References (23)

1. Bernards A., and Settleman J. GAP control: regulating the regulators of small GTPases. Trends Cell Biol. 14 (2004) 377-385
2. Kulkarni S.V., Gish G., Van der Geer P., Henkemeyer M., and Pawson T. Role of p120 ras-GAP in directed cell movement. J. Cell Biol. 149 (2000) 457-470
3. Yang J.-Y., and Widmann C. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol. Cell. Biol. 21 (2001) 5346-5358
4. Yang J.-Y., and Widmann C. The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NFκB activation. J. Biol. Chem. 277 (2002) 14641-14646
5. Yang J.-Y., Michod D., Walicki J., Murphy B.M., Kasibhatla S., Martin S., and Widmann C. Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions. Mol. Cell. Biol. 24 (2004) 10425-10436
6. Yang J.-Y., Walicki J., Michod D., Dubuis G., and Widmann C. Impaired Akt activity down-modulation, caspase-3 activation, and apoptosis in cells expressing a caspase-resistant mutant of RasGAP at position 157. Mol. Biol. Cell 16 (2005) 3511-3520
7. Michod D., Yang J.Y., Chen J., Bonny C., and Widmann C. A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells. Oncogene 23 (2004) 8971-8978
8. Michod D., and Widmann C. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins. Mol. Cancer Res. 5 (2007) 497-507
9. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
10. Valius M., Secrist J., and Kazlauskas A. The GTPase-activating protein of ras suppresses platelet-derived growth factor β receptor signaling by silencing phospholipase c-γ1. Mol. Cell. Biol. 15 (1995) 3058-3071
11. Kaufmann T., Schlipf S., Sanz J., Neubert K., Stein R., and Borner C. Characterization of the signal that directs Bcl-xL, but not Bcl-2, to the mitochondrial outer membrane. J. Cell Biol. 160 (2003) 53-64
12. Widmann C., Gibson S., and Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273 (1998) 7141-7147
13. Yang J.-Y., Walicki J., Abderrahmani A., Cornu M., Waeber G., Thorens B., and Widmann C. Expression of an uncleavable N-terminal RasGAP fragment in insulin-secreting cells increases their resistance toward apoptotic stimuli without affecting their glucose-induced insulin secretion. J. Biol. Chem. 280 (2005) 32835-32842
14. Trahey M., and McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238 (1987) 542-545
15. Gibbs J.B., Schaber M.D., Allard W.J., Sigal I.S., and Scolnick E.M. Purification of ras GTPase activating protein from bovine brain. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5026-5030
16. Pittet O., Petermann D., Michod D., Krueger T., Cheng C., Ris H.B., and Widmann C. Effect of the TAT-RasGAP317-326 peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. J. Photochem. Photobiol. B 88 (2007) 29-35
17. Labi V., Erlacher M., Kiessling S., and Villunger A. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death. Differ 13 (2006) 1325-1338
18. Youle R.J., and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9 (2008) 47-59
19. Yu J., Wang Z., Kinzler K.W., Vogelstein B., and Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1931-1936
20. Melan M.A., and Sluder G. Redistribution and differential extraction of soluble proteins in permeabilized cultured cells. Implications for immunofluorescence microscopy. J. Cell Sci. 101 (1992) 731-743
21. Lundberg M., and Johansson M. Is VP22 nuclear homing an artifact?. Nat. Biotechnol. 19 (2001) 713-714
22. Behrmann I., Smyczek T., Heinrich P.C., Schmitz-Van de L.H., Komyod W., Giese B., Muller-Newen G., Haan S., and Haan C. Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak·receptor complex to be equivalent to a receptor tyrosine kinase. J. Biol. Chem. 279 (2004) 35486-35493
23. Lundberg M., and Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291 (2002) 367-371